CNMD (CONMED Corporation) Stock Analysis - Hedge Fund Holdings

CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CNMD trades at $36.68 with a market cap of $1.10B and a P/E ratio of 24.16. CNMD moved +1.96% today. Year to date, CNMD is -11.63%; over the trailing twelve months it is -38.15%. Its 52-week range spans $33.21 to $78.00. Analyst consensus is neutral with an average price target of $39.24. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CNMD stock?

Hedge funds tracked by Rallies that own CNMD include Panagora Asset, Mangrove Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CONMED Corporation.

CNMD Key Metrics

Key financial metrics for CNMD
MetricValue
Price$36.68
Market Cap$1.10B
P/E Ratio24.16
EPS$1.52
Dividend Yield0.20%
52-Week High$78.00
52-Week Low$33.21
Volume70
Avg Volume0
Revenue (TTM)$1.37B
Net Income$47.05M
Gross Margin54.59%

Top Hedge Funds Holding CNMD

  • Panagora Asset holds 121.54K shares of CNMD, changed +9.83% as of Mar 31, 2026.
  • Mangrove Partners holds 12.22K shares of CNMD, changed +0.00% as of Mar 31, 2026.
  • Bridgewater Associates holds 5.93K shares of CNMD, changed +0.00% as of Sep 30, 2025.
  • Pinebridge Investments holds 339 shares of CNMD, changed +0.00% as of Jun 30, 2023.

Latest CNMD News

Recent CNMD Insider Trades

  • Glaze Richard sold 257 (~$10.59K) on Nov 21, 2025.
  • Garner Todd W sold 3.50K (~$150.50K) on Nov 6, 2025.
  • Farkas Charles sold 1.10K (~$59.05K) on Sep 12, 2025.

CNMD Analyst Consensus

4 analysts cover CNMD: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $39.24.

Common questions about CNMD

Who owns CNMD stock?
Hedge funds tracked by Rallies that own CNMD include Panagora Asset, Mangrove Partners, Bridgewater Associates, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CONMED Corporation.
Does Rallies show 13F holders for CNMD?
Yes. Rallies tracks hedge fund and 13F ownership data for CNMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CNMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNMD. It does not provide personalized investment advice.
CNMD

CNMD